12 High-Growth Micro-Cap Stocks to Buy Now
Over the past few years, focus has been on large-cap stocks and the magnificent seven that have delivered spectacular returns.
Insight Molecular Diagnostics Inc. (IMDX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Broadwood Capital Neal C. Bradsher | 11,931,839 | $39,136,432 | +5% | 2.76% |
| 2. | Pura Vida Investments Efrem Kamen | 947,134 | $3,106,600 | 20.88% | |
| 3. | Alyeska Investment Group Anand Parekh | 840,777 | $2,757,749 | 0.01% | |
| 4. | Millennium Management Israel Englander | 103,470 | $339,382 | +69% | 0% |
| 5. | Ghisallo Capital Management Michael Germino | 70,695 | $231,880 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | $0.00 | 12,684,884 | 2026-04-27 | Filing | |
| $3.64 | 250,923 | $913,133.89 | 12,684,884 | 2026-04-27 | Filing | |
| $0.00 | 0 | $0.00 | 12,433,961 | 2026-04-24 | Filing | |
| $3.53 | 38,880 | $137,083.10 | 12,433,961 | 2026-04-24 | Filing | |
| $0.00 | 0 | $0.00 | 12,395,081 | 2026-04-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.03 | 40,464 | $41,552.48 | 8,479,682 | 2022-06-24 | Filing | |
| $1.05 | 12,517 | $13,160.37 | 8,520,146 | 2022-06-24 | Filing | |
| $1.03 | 35,441 | $36,394.36 | 7,427,202 | 2022-06-24 | Filing | |
| $1.05 | 10,964 | $11,527.55 | 7,462,643 | 2022-06-24 | Filing | |
| $1.14 | 8,128 | $9,265.92 | 16,872 | 2022-05-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 182,561 | $1,077 | 0.39% | |
| 2. | 25 | $147 | 0% |
News See All
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q1 2026 Earnings Call Transcript
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q1 2026 Earnings Call Transcript May 13, 2026Insight Molecular Diagnostics Inc. beats earnings expectations.
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q4 2025 Earnings Call Transcript
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q4 2025 Earnings Call Transcript March 26, 2026Insight Molecular Diagnostics Inc. misses on earnings expectations.
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q3 2025 Earnings Call Transcript
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q3 2025 Earnings Call Transcript November 10, 2025Insight Molecular Diagnostics Inc. misses on earnings expectations.
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q2 2025 Earnings Call Transcript
Operator: Thank you everyone for joining. We'll start here shortly. Used to have a couple of people joining in, so give it a second more. Alright, everyone.
Hedge Fund Resource Center